Literature DB >> 33289907

Response to the United Nations Human Rights Council's Report on Race and Gender Discrimination in Sport: An Expression of Concern and a Call to Prioritise Research.

Blair R Hamilton1,2,3, Maria Jose Martinez-Patiño4, James Barrett3, Leighton Seal3, Ross Tucker5, Theodora Papadopoulou6,7,8,9, Xavier Bigard6,7,10, Alexander Kolliari-Turner1, Herbert Löllgen6, Petra Zupet6, Anca Ionescu6, Andre Debruyne6,7, Nigel Jones8,11, Juergen M Steinacker6,7,12, Karin Vonbank13, Giscard Lima1,14, Federica Fagnani14, Chiara Fossati14,15, Luigi Di Luigi7,14, Fabio Pigozzi6,7,14,15, Maurizio Casasco6,7,16, Michael Geistlinger7,17, Bernd Wolfarth7,18, Jane T Seto19,20, Norbert Bachl6,7,21,22, Richard Twycross-Lewis23, David Niederseer24, Andrew Bosch25, Jeroen Swart7,25, Demitri Constantinou7,26, Borja Muniz-Pardos27, José Antonio Casajus27, Victoriya Badtieva7,28,29, Irina Zelenkova27,28, James L J Bilzon7,8,30, Michiko Dohi7,31, Christian Schneider7,32, Sigmund Loland33, Michele Verroken34,35, Pedro Manonelles Marqueta36, Francisco Arroyo7,37, André Pedrinelli7,38, Konstantinos Natsis6,7,39, Evert Verhagen40, William O Roberts7,41, José Kawazoe Lazzoli7,42, Rogerio Friedman43, Ali Erdogan7,44, Ana V Cintron7,45, Shu-Hang Patrick Yung7,46, Dina C Janse van Rensburg7,47, Dimakatso A Ramagole7,47, Sandra Rozenstoka6,7,48, Felix Drummond6,7,49, Nick Webborn50, Fergus M Guppy1,2, Yannis P Pitsiladis51,52,53,54.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33289907      PMCID: PMC7721858          DOI: 10.1007/s40279-020-01380-y

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


× No keyword cloud information.
Dear Editor, Caster Semenya recently lost her appeal against the restriction of blood testosterone levels in female athletes [1] set by World Athletics [2, 3], requiring female athletes with “Disorders of Sex Development” (DSD) to reduce their blood testosterone concentrations to < 5 nmol/L for a period of at least six months, and then must maintain this lower blood testosterone continuously if they wish to remain eligible for events between 400 and 1500 m. This outcome opposes resolution 40/5, on race and gender discrimination in sport published by the United Nations Human Rights Council (UNHRC) which calls for the regulations to be revoked [4]. The UNHRC [4] and World Medical Association [5] argue that World Athletics regulation [2] denies DSD women the right to participate in certain events unless they accept “unnecessary medical intervention”, and that athletes are being coerced into such treatment. The authors agree that there is currently no direct scientific evidence that DSD women athletes with higher testosterone levels have a performance advantage in sporting events between 400 and 1500 m. This evidence will be difficult to obtain, given the low number of DSD athletes and the ethical considerations in such research. The principles that underlie a performance advantage as a result of biological differences created by male levels of testosterone have been argued by Handelsman et al. [6]. and are robust, but it is acknowledged that the evidence offered in support of the DSD policy creates a contradiction between the theory and evidence, since that policy requires hormonal control and applies to select events only. This selective ban is questionable, with athletes excelling in events at opposite ends of the restrictions such as American athlete Michael Johnson who held world records at 200 m and 400 m, as well as Herb McKenley, who won medals at 100, 200, and 400 m. Athletes have also performed at elite levels in the 1500 and 3000 m, the former of which is regulated by the policy, the latter is not. Given the influence of high testosterone concentrations, there is concern that 6 months of testosterone suppression is not long enough to negate potential advantages from life-long exposure. There is growing support for the idea that development influenced by high testosterone levels may result in retained anatomical and physiological advantages [7]. One such inherent “legacy” effect may be the phenomenon of muscle memory [8], that has been defined as the ability to rebuild muscle mass and strength after a long intervening period of inactivity and muscle mass loss [9]. The debate over sporting fairness, highlighted by the UNHRC, is particularly pertinent in DSD athletes [1, 10–13]. The argument is that DSD athletes competing in female sports possess potentially unfair advantages created by high levels of testosterone [8, 14–19]. To have meaningful competition, our current opinion is that the much higher than the normal female range in circulating testosterone levels in DSD needs to be mitigated [17, 20]. This action is intended to achieve a balance of fairness and safety while permitting inclusion, as reducing testosterone will reduce or eliminate the advantages conferred by androgens during puberty and development [21]. These measures are consistent with the idea that elite female competition forms a “protected category” with an entry that must be restricted by objective eligibility criteria. How DSD athletes are integrated into sport will depend on the balance of three philosophical arguments—sporting fairness, safety and inclusion. The sporting fairness and safety arguments are that all athletes competing should have a chance to succeed and an injury risk which each athlete is prepared to accept. As competitors, athletes accept that a degree of unfairness is inherent to sport since the best performing athletes usually possess genetically mediated advantages like the greater height of an athlete in basketball [22, 23], or architecture of skeletal muscle that determines whether an individual has the potential to become a champion sprinter or marathon runner, but not both [23-25]. However, not all natural advantages are left unregulated or uncategorised. Rules have been created for weight and age categories to maintain fairness and for safety reasons. In the absence of such categories, sporting competitions may lose their meaning, rewarding factors such as maturity/age or size/mass, rather than the attributes that sport is intended to reward. The same is true of biological sex, necessitating the separation of those who lack the performance-enhancing effects of testosterone from those who benefit from it. As advocates for sporting integrity and evidence-guided decision-making in sport, we empathise with the viewpoint of the UNHRC. However, abandoning eligibility regulations by allowing athletes to self-identify into women’s sport risks setting a precedent for the integrity of sport, which would pose a health risk to women athletes when biologically male athletes compete in heavy contact sports such as boxing while posing a negligible safety risk to women in sports such as golf. In most running events, for instance, an advantage of 10–15% is often seen in biologically male athletes in comparison with biologically female athletes [26]. If a biologically male athlete self-identifies as a female, legitimately with a diagnosis of gender dysphoria [27] or illegitimately to win medals [28], the athlete already possesses a physiological advantage that undermines fairness and safety. This is not equitable, nor consistent with the fundamental principles of the Olympic Charter [29] and could be a potential danger to the health and safety of athletes. These situations unequivocally demonstrate that eligibility rules are necessary but as previously stated, they need to be proportionate and evidence based. Athletes need to be aware of the consequences and obligations of choosing to compete in a protected class and the decision to pursue the necessary therapy for eligibility in that class must belong with the athlete. If athletes are fully informed about the treatment requirements and consequences, they can make an informed choice in what is best for them as individuals. As outlined by the UNHRC, the line between consent and coercion must not be blurred, athlete well-being must be the primary determinant of treatment and no athlete should be coerced into a choice that may harm their long-term health. However, if an athlete is fully informed and consents, then it is their free choice to compete and free choice is a fundamental human right. If there were no eligibility rules, sport would lose its integrity and near-universal support, and as we have seen during the COVID-19 crisis, sport is much poorer without supporters. Without rules that are perceived as fair, sport will not engage the younger generation and likely negatively impact future participation rates in the female category, particularly with self-identification at the elite level.
  4 in total

1.  Effects of moderately increased testosterone concentration on physical performance in young women: a double blind, randomised, placebo controlled study.

Authors:  Angelica Lindén Hirschberg; Jona Elings Knutsson; Torbjörn Helge; Manne Godhe; Maria Ekblom; Stephane Bermon; Björn Ekblom
Journal:  Br J Sports Med       Date:  2019-10-15       Impact factor: 13.800

2.  The Fluidity of Gender and Implications for the Biology of Inclusion for Transgender and Intersex Athletes.

Authors:  Joanna Harper; Giscard Lima; Alexander Kolliari-Turner; Fernanda Rossell Malinsky; Guan Wang; Maria Jose Martinez-Patino; Siddhartha S Angadi; Theodora Papadopoulou; Fabio Pigozzi; Leighton Seal; James Barrett; Yannis P Pitsiladis
Journal:  Curr Sports Med Rep       Date:  2018-12       Impact factor: 1.733

3.  Morphology, enzyme activities and buffer capacity in leg muscles of Kenyan and Scandinavian runners.

Authors:  B Saltin; C K Kim; N Terrados; H Larsen; J Svedenhag; C J Rolf
Journal:  Scand J Med Sci Sports       Date:  1995-08       Impact factor: 4.221

Review 4.  Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance.

Authors:  David J Handelsman; Angelica L Hirschberg; Stephane Bermon
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

  4 in total
  3 in total

1.  How is the Topic of Intersex Athletes in Elite Sports Positioned in Academic Literature Between January 2000 and July 2022? A Systematic Review.

Authors:  Marisa Jensen; Jörg Schorer; Irene R Faber
Journal:  Sports Med Open       Date:  2022-10-20

Review 2.  Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus Statement.

Authors:  Blair R Hamilton; Giscard Lima; James Barrett; Leighton Seal; Alexander Kolliari-Turner; Guan Wang; Antonia Karanikolou; Xavier Bigard; Herbert Löllgen; Petra Zupet; Anca Ionescu; Andre Debruyne; Nigel Jones; Karin Vonbank; Federica Fagnani; Chiara Fossati; Maurizio Casasco; Demitri Constantinou; Bernd Wolfarth; David Niederseer; Andrew Bosch; Borja Muniz-Pardos; José Antonio Casajus; Christian Schneider; Sigmund Loland; Michele Verroken; Pedro Manonelles Marqueta; Francisco Arroyo; André Pedrinelli; Konstantinos Natsis; Evert Verhagen; William O Roberts; José Kawazoe Lazzoli; Rogerio Friedman; Ali Erdogan; Ana V Cintron; Shu-Hang Patrick Yung; Dina C Janse van Rensburg; Dimakatso A Ramagole; Sandra Rozenstoka; Felix Drummond; Theodora Papadopoulou; Paulette Y O Kumi; Richard Twycross-Lewis; Joanna Harper; Vasileios Skiadas; Jonathan Shurlock; Kumpei Tanisawa; Jane Seto; Kathryn North; Siddhartha S Angadi; Maria Jose Martinez-Patiño; Mats Borjesson; Luigi Di Luigi; Michiko Dohi; Jeroen Swart; James Lee John Bilzon; Victoriya Badtieva; Irina Zelenkova; Juergen M Steinacker; Norbert Bachl; Fabio Pigozzi; Michael Geistlinger; Dimitrios G Goulis; Fergus Guppy; Nick Webborn; Bulent O Yildiz; Mike Miller; Patrick Singleton; Yannis P Pitsiladis
Journal:  Sports Med       Date:  2021-03-24       Impact factor: 11.928

3.  Joint position statement of the International Federation of Sports Medicine (FIMS) and European Federation of Sports Medicine Associations (EFSMA) on the IOC framework on fairness, inclusion and non-discrimination based on gender identity and sex variations.

Authors:  Fabio Pigozzi; Xavier Bigard; Juergen Steinacker; Bernd Wolfarth; Victoriya Badtieva; Christian Schneider; Jeroen Swart; James Lee John Bilzon; Demitri Constantinou; Michiko Dohi; Luigi Di Luigi; Chiara Fossati; Norbert Bachl; Guoping Li; Theodora Papadopoulou; Maurizio Casasco; Dina Christina Christa Janse van Rensburg; Jean-François Kaux; Sandra Rozenstoka; Jose-Antonio Casajus; Irina Zelenkova; Emre Ak; Bulent Ulkar; Francisco Arroyo; Anca Ionescu; André Pedrinelli; Mike Miller; Patrick Singleton; Malav Shroff; Nick Webborn; James Barrett; Blair Hamilton; Michael Geistlinger; Gianfranco Beltrami; Sergio Migliorini; Lenka Dienstbach-Wech; Stéphane Bermon; Yannis P Pitsiladis
Journal:  BMJ Open Sport Exerc Med       Date:  2022-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.